Abstract
It is now well-established that human papillomavirus (HPV)-associated squamous cell carcinoma, which comprises an increasing proportion of all oropharyngeal cancers, represents a unique entity with distinct clinical and molecular characteristics. Data also has emerged demonstrating that patients with HPVpositive head and neck cancer have an improved prognosis compared to their HPV-negative counterparts, with several series showing that patients with HPV-related tumors arising from the oropharynx have at least half the risk of death. However, these studies have been complicated by such factors as the limited quality of data, small sample sizes, as well as the variability in treatment, inclusion criteria, and follow-up. Although the exact reason for the improved survival among HPV-positive patients is unclear, many investigators have proposed that HPV-related head and neck cancer is more sensitive to the effects of radiation therapy than HPVnegative tumors arising in the setting of traditional environmental exposures. Despite the attractiveness of this hypothesis, the data focusing on possible de-intensification approaches remains preliminary, and treatment paradigms will likely continue to evolve as findings from innovative clinical trials yield answers to many provocative questions.
Keywords: Cancer, head and neck, HPV, radiation, squamous cell.
Current Cancer Therapy Reviews
Title:Evolving Treatment Paradigms for HPV-Related Oropharynx Cancer
Volume: 10 Issue: 4
Author(s): Allen M. Chen, Deborah Wong and Maie St. John
Affiliation:
Keywords: Cancer, head and neck, HPV, radiation, squamous cell.
Abstract: It is now well-established that human papillomavirus (HPV)-associated squamous cell carcinoma, which comprises an increasing proportion of all oropharyngeal cancers, represents a unique entity with distinct clinical and molecular characteristics. Data also has emerged demonstrating that patients with HPVpositive head and neck cancer have an improved prognosis compared to their HPV-negative counterparts, with several series showing that patients with HPV-related tumors arising from the oropharynx have at least half the risk of death. However, these studies have been complicated by such factors as the limited quality of data, small sample sizes, as well as the variability in treatment, inclusion criteria, and follow-up. Although the exact reason for the improved survival among HPV-positive patients is unclear, many investigators have proposed that HPV-related head and neck cancer is more sensitive to the effects of radiation therapy than HPVnegative tumors arising in the setting of traditional environmental exposures. Despite the attractiveness of this hypothesis, the data focusing on possible de-intensification approaches remains preliminary, and treatment paradigms will likely continue to evolve as findings from innovative clinical trials yield answers to many provocative questions.
Export Options
About this article
Cite this article as:
M. Chen Allen, Wong Deborah and St. John Maie, Evolving Treatment Paradigms for HPV-Related Oropharynx Cancer, Current Cancer Therapy Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/157339471004150407140835
DOI https://dx.doi.org/10.2174/157339471004150407140835 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue "Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics" aims to explore cutting-edge developments and innovative strategies in the field of lipid nanoparticle (LNP) technology, particularly focusing on its application in mRNA delivery. This topic has gained unprecedented attention and urgency in the wake of the COVID-19 ...read more
Current Progress in Protein Degradation and Cancer Therapy
Targeted Protein Degradation is gaining momentum in cancer therapy; it facilitates targeting undruggable proteins, overcomes cancer resistance, and avoids undesirable side effects. Thus small molecule degraders have emerged as novel therapeutic strategies. Targeted protein degradation (TPD), the process of eliminating a protein of interest holds a great promise for the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery Flavonoids for Allergic Diseases: Present Evidence and Future Perspective
Current Pharmaceutical Design Analysis of Simple Sequence Repeats in Mammalian Cell Cycle Genes
Recent Advances in DNA & Gene Sequences (Discontinued) Tumor Invasion and Oxidative Stress: Biomarkers and Therapeutic Strategies
Current Molecular Medicine Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets 10 Years of SELDI: What Have we Learnt?
Current Proteomics Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy
Current Drug Targets Progesterone Receptor Membrane Component 1 and its Accomplice: Emerging Therapeutic Targets in Lung Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine Nutraceuticals in Psychiatric Practice
Recent Patents on CNS Drug Discovery (Discontinued) Targeted Therapy for Glioblastoma: Lessons Learned and Future Directions
Current Cancer Therapy Reviews Celecoxib in Cancer Therapy and Prevention – Review
Current Drug Targets Epidermal Growth Factor Receptors: A Functional Perspective
Current Radiopharmaceuticals Imaging Reporters and Multimodal Molecular Bio-Imaging: A Database of Available Probes for Multi-Modality Bio-Imaging of Reporter Gene Expression
Recent Patents on Medical Imaging Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review
Recent Patents on Anti-Cancer Drug Discovery Clinical and Forensic Signs Related to Cocaine Abuse
Current Drug Abuse Reviews Copper Compounds in Anticancer Strategies
Current Medicinal Chemistry Implementing Cancer Exercise Rehabilitation: An Update on Recommendations for Clinical Practice
Current Cancer Therapy Reviews Application of Chitosan and Propolis in Endodontic Treatment: A Review
Mini-Reviews in Medicinal Chemistry The Radioprotective Potentials of Silymarin/Silibinin Against Radiotherapy- Induced Toxicities: A Systematic Review of Clinical and Experimental Studies
Current Medicinal Chemistry